DS
GEVA

David Shaw’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

David Shaw’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50,303
Closed -$4.91M – 4026
2015
Q1 		$4.91M Buy
+50,303
New +$5.33M 0.01% 1395
2014
Q4 		– Sell
-23,289
Closed -$1.6M – 4490
2014
Q3 		$1.6M Sell
23,289
-125
-0.5% -$8.95K ﹤0.01% 2405
2014
Q2 		$2.45M Sell
23,414
-56,670
-71% -$4.82M ﹤0.01% 2144
2014
Q1 		$6.64M Buy
+80,084
New +$7.41M 0.01% 1350

David Shaw's GEVA Position: Q2 2015 in Review

David Shaw sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 50,303 shares — an estimated $4.91M sold.

David Shaw first reported a position in GEVA in Q1 2014 and held it in 4 quarters. The position peaked at $6.64M in Q1 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • David Shaw reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • David Shaw sold 50,303 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $4.91M.
  • David Shaw first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 4 quarters.
  • David Shaw's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $6.64M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.